Patterns for RANTES Secretion and Intercellular Adhesion  Molecule 1 Expression Mediate Transepithelial T Cell Traffic  Based on Analyses In Vitro and In Vivo by Taguchi, Masahiko et al.
 
1927
 
J. Exp. Med. 
 
Ó
 
 The Rockefeller University Press • 0022-1007/98/06/1927/14 $2.00
Volume 187, Number 12,June 15, 19981927–1940
http://www.jem.org
 
Patterns for RANTES Secretion and Intercellular Adhesion 
Molecule 1 Expression Mediate Transepithelial T Cell Trafﬁc 
Based on Analyses In Vitro and In Vivo
 
By Masahiko Taguchi,
 
*
 
‡
 
 Deepak Sampath,
 
*
 
‡
 
 Takeharu Koga,
 
*
 
Mario Castro,
 
*
 
 Dwight C. Look,
 
*
 
 Shin Nakajima,
 
*
 
and Michael J. Holtzman
 
*
 
‡
 
From the 
 
*
 
Department of Internal Medicine and the 
 
‡
 
Department of Cell Biology and Physiology, 
Washington University School of Medicine, St. Louis, Missouri 63110
 
Summary
 
Immune cell migration into and through mucosal barrier sites in general and airway sites in
particular is a critical feature of immune and inflammatory responses, but the determinants of
transepithelial (unlike transendothelial) immune cell traffic are poorly defined. Accordingly, we
used primary culture airway epithelial cells and peripheral blood mononuclear cells to develop
a cell monolayer system that allows for apical-to-basal and basal-to-apical T cell transmigration
that can be monitored with quantitative immunofluorescence flow cytometry. In this system,
T cell adhesion and subsequent transmigration were blocked in both directions by monoclonal
antibodies (mAbs) against lymphocyte function-associated antigen 1 (LFA-1) or intercellular
 
adhesion molecule 1 (ICAM-1) (induced by interferon 
 
g
 
 [IFN-
 
g
 
] treatment of epithelial cells).
The total number of adherent plus transmigrated T cells was also similar in both directions, and
this pattern fit with uniform presentation of ICAM-1 along the apical and basolateral cell sur-
faces. However, the relative number of transmigrated to adherent T cells (i.e., the efficiency of
transmigration) was increased in the basal-to-apical relative to the apical-to-basal direction, so
an additional mechanism was needed to mediate directional movement towards the apical sur-
face. Screening for epithelial-derived 
 
b
 
-chemokines indicated that IFN-
 
g
 
 treatment caused se-
lective expression of RANTES (regulated upon activation, normal T cell expressed and se-
creted), and the functional significance of this finding was demonstrated by inhibition of
epithelial–T cell adhesion and transepithelial migration by anti-RANTES mAbs. In addition,
we found that epithelial (but not endothelial) cells preferentially secreted RANTES through
the apical cell surface thereby establishing a chemical gradient for chemotaxis across the epithe-
lium to a site where they may be retained by high levels of RANTES and apical ICAM-1.
These patterns for epithelial presentation of ICAM-1 and secretion of RANTES appear pre-
served in airway epithelial tissue studied either ex vivo with expression induced by IFN-
 
g
 
treatment or in vivo with endogenous expression induced by inflammatory disease (i.e.,
asthma). Taken together, the results define how the patterns for uniform presentation of
ICAM-1 along the cell surface and specific apical sorting of RANTES may serve to mediate
the level and directionality of T cell traffic through epithelium (distinct from endothelium) and
provide a basis for how this process is precisely coordinated to route immune cells to the mu-
cosal surface and maintain them there under normal and stimulated conditions.
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T
 
cell trafficking into epithelial barriers (including gut,
skin, and airway) may be critical for mucosal immu-
nity and epithelial barrier function, but the basis for T cell
movement into and through the epithelium is poorly de-
fined. Schemes for transendothelial movement of T cells
(extravasation) have been defined that depend on the coor-
dinated expression of cell adhesion molecules and 
 
b
 
-chemo-
kines that interact with corresponding receptors on the
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lymphocyte surface (1). Thus, it might appear reasonable to
propose that similar molecular mechanisms may regulate
transepithelial movement of T cells. However, there are
critical differences between epithelial and endothelial cell
adhesion and transmigration, the most obvious of which
may be that immune cell recruitment through endothelium
and epithelium generally occur in opposite directions with
respect to the cell’s luminal surface and the bloodstream.
For endothelium, the abluminal direction is apical-to-basal,
whereas for epithelium, it is basal-to-apical. In the case of
the endothelium, it appears that this directional process is
coordinated by the actions of selectins, cell adhesion mole-
cules, and chemokines, but the driving force for T cell
movement across the epithelial barrier (if it exists at all) is
uncertain.
Accordingly, we developed a system for monitoring T
cell adhesion and transmigration through an epithelial
model in apical-to-basal and basal-to-apical directions. T cell
behavior was monitored by quantitative flow cytometry to
avoid a need for extensive leukocyte purification, culture,
and/or labeling—steps that may alter leukocyte function
and, by their nature, may eliminate heterotypic cell–cell in-
teractions that may be important in vivo. Monolayers were
established with primary-culture human tracheobronchial
epithelial cells (hTBECs)
 
1
 
 that exhibit differentiated struc-
tural and functional features of polarized epithelial barriers
found in situ (2). In particular, monolayers of hTBECs em-
ulate in vivo
 
 
 
behavior with low basal levels of intercellular
adhesion molecule (ICAM)-1 and cytokine-dependent in-
creases in ICAM-1 expression (3, 4) governed chiefly by se-
lective responsiveness of a specific IFN-
 
g
 
–driven signal
transduction pathway leading from the cell surface to the
ICAM-1 gene promoter region in the nucleus (5–7). Ex-
pression of epithelial ICAM-1 and consequent interaction
with T cell lymphocyte function-associated antigen 1
(LFA-1) appears to be the major determinant of T cell ad-
hesion to the apical surface of the hTBEC monolayers (8,
9), but, as noted above, the extent to which ICAM-1–
LFA-1 interaction or other molecular interactions might
regulate T cell traffic through the epithelium and the direc-
tionality of movement was uncertain for airway and other
epithelia. These findings obtained ex vivo now provide a
molecular basis for T cell traffic into and through mucosal
barriers based on the polarized secretion of the 
 
b
 
-chemo-
kine RANTES (regulated upon activation, normal T cell
expressed and secreted) in the setting of uniform presenta-
tion of ICAM-1 along the cell surface. In addition, we
present immunohistochemical and in situ hybridization
data from normal and inflamed airway tissue to support the
relevance of these patterns of expression for RANTES and
ICAM-1 to mediate immune cell traffic in human subjects.
 
Taken together with comparative data for endothelial cells,
the findings offer a means for progressive movement from
endothelium to environment through distinct cell-specific
mechanisms for cell adhesion molecule expression and
chemokine secretion.
 
Materials and Methods
 
Materials.
 
Recombinant human IFN-
 
g
 
 and TNF-
 
a
 
 were
gifts from Genentech Corp. (South San Francisco, CA); Ficoll-
Hypaque was from Pharmacia (Piscataway, NJ); fluorospheres
(Coulter Standard-Brite) that emit from 525 to 700 nm were
from Coulter Cytometry (Miami, FL); streptavidin–Red 670 was
from GIBCO BRL (Gaithersburg, MD); collagen (vitrogen 100)
was from Celtrix Laboratories (Santa Clara, CA); Citra solution
was from Biogenex (San Ramon, CA); 4-
 
b
 
-phorbol-12,13-dibu-
tyrate, purified mouse IgG
 
1
 
, and other chemicals were from
Sigma Chemical Co. (St. Louis, MO). Laboratory of Human
Carcinogenesis (LHC) basal medium was obtained from Biofluids
(Rockville, MD) and was supplemented with bovine pituitary
extract, insulin, hydrocortisone, epidermal growth factor, trans-
ferrin, epinephrine, triiodothyronine, 
 
l
 
-glutamine, calcium chlo-
ride, trace elements, penicillin, and streptomycin (LHC-8e) as
described previously (8, 10). The cDNA for RANTES in pBlue-
script was a gift from T. Schall (DNAX, Palo Alto, CA; refer-
ence 11).
 
Antibodies.
 
Antibodies were obtained as follows: anti–ICAM-1
(CD54) mAb R6.5 (as an F[ab] fragment; reference 12) was a gift
from R. Rothlein (Boehringer Ingelheim Pharmaceuticals, Inc.,
Ridgefield, CT); anti-ICAM mAb 84H10 was obtained from
Immunotech, Inc. (Westbrook, ME); anti-
 
b
 
2
 
-integrin (LFA-1
 
b
 
,
CD18) mAb producing hybridoma cell line TS1/18.1.2.11 (13)
was obtained from the American Type Culture Collection
(Rockville, MD) and intraperitoneal injection into BALB/c mice
was used to produced ascites fluid enriched for mAb (14); one
anti-RANTES IgG
 
1
 
 mAb and two affinity-purified goat anti-
RANTES IgGs were gifts from T. Schall (DNAX, Palo Alto,
CA); another anti-RANTES mAb and an affinity-purified goat
anti-RANTES IgG were obtained from R&D Systems (Minne-
apolis, MN); anti-CD3 mAb Leu-4 conjugated with FITC or bi-
otin (for T cell detection), anti–TCR-
 
a/b
 
 mAb TCR-
 
a/b
 
-1
conjugated with FITC, anti–TCR-
 
g/d
 
 mAb TCR-
 
g/d
 
-1 conju-
gated with PE, goat anti–mouse IgG
 
1
 
 conjugated with FITC, and
negative control mAbs consisting of mouse IgG
 
1
 
 conjugated with
FITC or PE were obtained from Becton Dickinson (Mountain
View, CA); anti-Na,K-ATPase (
 
a
 
1 subunit) Ab was a gift from
R. Mercer (Washington University, St. Louis, MO; reference 15).
 
Epithelial Cell Isolation and Culture.
 
Human tracheal tissue was
obtained from lung transplant donors and routine autopsies (2–24 h
postmortem). Subjects with lung disease were excluded from
study. hTBECs were isolated from tracheal mucosal strips by en-
zymatic dissociation and then were cultured in LHC-8e medium
on flasks coated with collagen/albumin as described previously
(8). Cells were passaged by treatment with 0.05% trypsin/0.02%
EDTA and studied up to passage 7.
To prepare standard (upright) epithelial cell monolayers, hTBECs
were cultured to confluence on collagen-coated polycarbonate
membrane inserts (8-
 
m
 
m pore size, 6.5-mm diam) in Transwell
cell culture chambers (Costar, Cambridge, MA). Preliminary ex-
periments confirmed that T cells do not adhere to inserts and pass
through freely if no cell monolayer is present. To create inverted
monolayers, membrane inserts were inverted and the bottom side
 
1
 
Abbreviations used in this paper:
 
 HUVEC, human umbilical vein endothe-
lial cell; hTBEC, human tracheobronchial epithelial cell; ICAM, intercel-
lular adhesion molecule 1; LFA, lymphocyte function-associated antigen;
LHC, Laboratory of Human Carcinogenesis; MCP, monocyte chemoat-
tractant protein; RANTES, regulated upon activation, normal T cell ex-
pressed and secreted. 
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was fitted with a section of a 1.7-ml microcentrifuge tube similar
to methods described previously (16, 17). Cells were cultured to
confluence on this bottom side (5–6 d), and then the microcen-
trifuge tube was removed and the inserts were placed upright into
24-well culture plates for an additional day before assay. Mono-
layer confluence was verified by Diff-Quik stain (Baxter, McGaw
Park, IL), and monolayer integrity was monitored using transepi-
thelial electrical resistance (17, 18). Electrical potential difference
(PD) after passage of a defined current pulse was determined us-
ing a two-electrode volt–ohm meter (World Precision Instru-
ments, Inc., Sarasota, FL); only monolayers showing stable resis-
tance of 
 
.
 
120 ohm
 
 3 
 
cm
 
2
 
 and 100% confluency were used for
assay. Cell monolayers grew only on the plated side of the filter,
and under these culture conditions, maintained epithelial-specific
characteristics of differentiated structure and function (19).
 
Conditions for Adhesion/Transmigration Assay.
 
These conditions
were modified from those described previously for determining
epithelial–T cell adhesion (8, 9). The mononuclear leukocyte
fraction was isolated from peripheral blood of healthy donors by a
one-step gradient through Ficoll-Hypaque. The PBMC fraction
was resuspended in LHC-8e, and aliquots of 3 
 
3 
 
10
 
5
 
 leukocytes/
100 
 
m
 
l were added to the upper compartment of each Transwell
chamber. Leukocytes were pretreated with or without phorbol
dibutyrate (50 ng/ml for 15 min) and epithelial monolayers were
pretreated with or without IFN-
 
g
 
 (100 units/ml for 24 h); each
was then washed with LHC-8e. A phorbol dibutyrate concentra-
tion was chosen that causes maximal lymphocyte adherence (20),
and an IFN-
 
g
 
 concentration was chosen that causes maximal ad-
herence and ICAM-1 and RANTES expression (3, 9, 21). To
some tissue culture wells, leukocytes were added that had been
pretreated with anti–LFA-1
 
b
 
 mAb (30 
 
m
 
g/ml) for 30 min at
37
 
8
 
C. In other wells, the cell monolayer was pretreated with
anti–ICAM-1 mAb R6.5 F(ab) fragment (50 
 
m
 
g/ml) or anti-
RANTES mAb (10 
 
m
 
g/ml) for 30 min at 37
 
8
 
C. Antibody con-
centrations were used which caused maximal inhibition of leuko-
cyte adherence (8, 9), and antibodies were not removed during
the subsequent adherence/transmigration period. Leukocyte ad-
herence/transmigration was then allowed to occur for 1–4 h at
37
 
8
 
C in 5% CO
 
2
 
. Nonadherent leukocytes were removed by
gently washing each well three times, and then adherent and
transmigrated leukocytes were recovered as separate populations.
Adherent leukocytes were removed by treatment with 0.05%
trypsin/0.02% EDTA for 10 min at 37
 
8
 
C followed by neutraliza-
tion with PBS containing 10% fetal bovine serum. Preliminary
experiments established that these dissociation conditions did not
alter flow cytometry determinants and resulted in maximal recov-
ery of adherent leukocytes with no significant decrease in cell vi-
ability and no residual leukocytes adherent to the monolayer. For
inverted monolayers, T cells freely cross the insert, and so were
observed to adhere only to the monolayer on the underside of the
filter. Microscopy of monolayers and complete dissociation of
cells with trypsin each indicated that 
 
,
 
0.1% of leukocytes were
retained within the monolayer. Transmigrated leukocytes were
recovered from the lower chamber by aspiration of medium.
 
Flow Cytometry Analysis of Adherent and Transmigrated Leuko-
cytes.
 
Using an approach we have described previously (8, 9), al-
iquots from the starting mononuclear leukocyte preparation
added to the monolayer and from the adherent and transmigrated
leukocytes from each monolayer well were analyzed by fluores-
cence-activated flow cytometry in order to determine the num-
ber and percentage of adherent and transmigrated T cells for each
condition. Each sample was washed and resuspended in PBS con-
taining 1% FBS, incubated with 5 
 
m
 
l of anti-CD3 mAb (to distin-
guish T cells from other types of leukocytes or epithelial cells) for
1 h at 4
 
8
 
C followed by FITC-conjugated goat anti–mouse IgG
for 1 h at 4
 
8
 
C, and then washed again and resuspended in 200 
 
m
 
l
PBS containing 0.2% BSA. Next, 10
 
4
 
 fluorospheres (to serve as
an internal standard for quantitation) were added to each sample,
and the samples were analyzed using an Epics Elite flow cytome-
ter (Coulter Cytometry, Hialeah, FL). Gating conditions were es-
tablished for the clearest separation of T cells and resulted in the
use of a multivariate analysis of cell side scatter versus forward
scatter as described previously (8, 9). Data was acquired (Coulter
Elite Version 3 software; Coulter Cytometry) using 1,024-chan-
nel resolution over a four decade log gain setting. The software
was set up to calculate the percentages of T cells and fluoro-
spheres in each sample based on 30,000 events, and the number
of fluorospheres added to the sample was calculated based on the
manufacturer’s specifications. The number of adherent or trans-
migrated T cells and percent adherence or transmigration in each
sample was determined by the following equations: number of
adherent or transmigrated T cells 
 
5 
 
(percent T cells)/(percent
fluorospheres) 
 
3 
 
(number of fluorospheres added to the sample);
percent adherence or transmigration 
 
5 
 
(number of adherent or
transmigrated T cells/number of T cells added to the monolayer)
 
3 
 
100. Preliminary experiments indicated a high correlation (
 
r
 
 
 
5
 
0.99) between measurements of leukocytes by flow cytometry
versus the values obtained for manual cell counting. For experi-
ments analyzing 
 
a/b
 
– versus 
 
g/d
 
–T cell behavior, the same pro-
tocol was followed except that samples were incubated with 5 
 
m
 
l
biotin-conjugated anti-CD3 mAb followed by streptavidin–Red
670, 5 
 
m
 
l FITC-conjugated anti–TCR-
 
a/b
 
 mAb, and 5 
 
m
 
l PE-
conjugated anti–TCR-
 
g/d
 
 mAb for 1 h at 4
 
8
 
C, and then resus-
pended in 200 
 
m
 
l PBS containing 0.2% BSA. Exclusive gating
conditions for separation of 
 
a/b
 
- and 
 
g/d
 
-bearing T cells was ac-
complished as noted previously (8).
 
Immunocytochemistry for ICAM-1.
 
Epithelial cell monolayers
were cultured in Transwell chambers and treated with or without
IFN-
 
g
 
 as described above. After treatment, the cell monolayers
were fixed in methanol for 6 min at 
 
2
 
20
 
8
 
C, pretreated with 2%
gelatin in PBS for 1 h at 25
 
8
 
C to block nonspecific Ig binding,
and then incubated with anti–ICAM-1 mAb 84H10 (1 
 
m
 
g/ml)
and 2% gelatin in PBS for 1 h at 25
 
8
 
C. Next, the cells were rinsed
with PBS, and then treated with FITC-conjugated goat anti–
mouse IgG
 
1
 
 (1:20, vol/vol in PBS with 2% gelatin) for 1 h at
25
 
°
 
C. In addition, cells were incubated with anti-Na,K-ATPase
Ab (5 
 
m
 
g/ml) followed by Cy-3–conjugated goat anti–mouse
IgG to define the basolateral cell membrane (15, 22). Immunoflu-
orescent cells were then viewed using Zeiss Axioplan microscope
equipped with a laser confocal imaging system (MRC-500; Bio-
Rad Labs., Hercules, CA) and scanned along the z-axis in 2-
 
m
 
m
steps. Images were generated at 
 
3
 
600 via a computer interface.
 
Immunoassay for RANTES.
 
Epithelial cell monolayers were
cultured in Transwell chambers and treated with or without IFN-
 
g
 
as described above. After treatment, monolayers were washed and
then incubated for a 4-h adherence/transmigration period with-
out or with PBMCs (untreated or treated with phorbol dibutyrate),
and media from the upper and lower chambers was collected for
RANTES levels using an enzyme-linked immunosorbent assay
(R&D Systems, Minneapolis, MN). For comparison, apical and
basal secretion of RANTES was also monitored in epithelial
(hTBEC) versus human umbilical vein endothelial cell (HUVEC)
monolayers treated with or without IFN-
 
g
 
 (100 units/ml) as well
as IFN-
 
g
 
 plus TNF-
 
a
 
 (100 units/ml) to maximize RANTES
generation and release (21, 23).
 
Epithelial Tissue Procurement.
 
Endobronchial biopsy tissue was 
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obtained by fiberoptic bronchoscopy using a University-approved
protocol for healthy nonasthmatic control subjects (six male and
four female aged 20–54 yr) and stable asthmatic subjects (three
male and eight female aged 22–60 yr). Nonasthmatic subjects had
no clinical history of asthma, normal spirometry (forced expiratory
volume in 1s; FEV
 
1
 
 
 
5 
 
108 
 
6
 
 14% predicted; range 
 
5 
 
81–129%
predicted), and normal airway reactivity to inhaled methacholine
(provocative concentration for 20% decrease in FEV
 
1
 
; FEV
 
1
 
 PC
 
20
 
 
 
.
 
16 mg/ml). Asthmatic subjects met clinical diagnostic criteria for
asthma (24) and had more variable spirometry (FEV
 
1
 
 
 
5 
 
90 6
12% predicted; range 66–111% predicted) and hyperreactivity to
inhaled methacholine (FEV1 PC20 5 1.40 6 1.20 mg/ml; range,
0.12–2.80 mg/ml). Positive prick skin test reactivity to a panel of
allergens (house dust, trees, grasses, fungi, and dog and cat dan-
der) was present in nine of the asthmatic subjects and three of the
control subjects. Asthmatic subjects were treated with inhaled tri-
amcinolone (1,600 mg/d) or fluticasone (1,760 mg/d) for 30 d
before the first endobronchial biopsy. Glucocorticoid treatment
was then discontinued, and subjects were monitored for an addi-
tional 6 wk or until peak expiratory flow had decreased by 20% at
which time a second endobronchial biopsy was obtained.
Immunohistochemistry for ICAM-1 and RANTES. For ICAM-1
immunostaining, endobronchial biopsies were frozen in OCT/
TBS (optimum cutting temperative/Triangular Biomedical Science)
and cut into 6-mm thick sections that were washed in Tris-buf-
fered saline, blocked by treatment with 2% gelatin, and incubated
with anti–ICAM-1 mAb (1 mg/ml) for 18 h at 48C. Primary Ab
binding was detected with an FITC-conjugated donkey anti–
mouse IgG secondary Ab and viewed by laser confocal micros-
copy as described above. In addition, some endobronchial biop-
sies were incubated in 8-well LabTek chambers containing LHC-8e
media without and with IFN-g (100 units/ml) for 24 h at 378C.
These biopsies (explants) were then frozen, sectioned, and immu-
nostained for ICAM-1 in the same manner. Immunofluorescent
sections were then viewed by laser confocal microscopy as de-
scribed above.
For RANTES immunostaining, biopsies were fixed in 10%
formalin, embedded in paraffin, and cut into 6-mm sections. Tis-
sue sections were deparaffinized with xylene, rehydrated with
graded ethanol solutions, and endogenous peroxidase activity was
blocked by treatment with 3% hydrogen peroxide for 30 min at
258C. Antigen exposure was facilitated by an antigen-retrieval
method in which tissue specimens were placed in 10 mM Citra
solution for 10 min at 988C. After tissue specimens cooled to
room temperature, nonspecific antigens were blocked by expo-
sure to 5% nonimmune rabbit serum for 30 min at 258C. Slides
were then incubated with goat anti–human RANTES Ab (5 mg/ml)
or nonimmune IgG for 24 h at 48C. Excess free primary antibody
was removed by washing with Tris-buffered saline, and bound
antibody was detected by sequential incubation with a biotiny-
lated rabbit anti–goat IgG secondary antibody (7.5 mg/ml) for 30
min at 258C and then a preformed streptavidin–horseradish
peroxidase complex (1:400 vol/vol) for 30 min at 258C. The per-
oxidase reaction was carried out by exposure to 0.6 mM 3,39-
diaminobenzidine-HCl, 3 mM hydrogen peroxide, and 50 mM
Tris-HCl (pH 7.6) for 30 min. Sections were then washed with
water, lightly counterstained with hematoxylin, and dehydrated
with graded ethanol solutions. Sections of tonsillar tissue pro-
cessed with the same protocol served as a positive control for
RANTES immunostaining. All sections were then viewed using
a photomicrography system (model D-7082; Carl Zeiss, Inc.,
Thornwood, NY).
In Situ Hybridization for RANTES. For RANTES riboprobe
synthesis, a 0.41-kb human cDNA fragment (nt 1–410) was posi-
tionally cloned into the EcoRI and HindIII sites of pBluescript
(Promega Corp., Madison, WI) in order to generate pBluescript-
RANTES (1–410). Radiolabeled 35S-UTP sense and antisense
cRNA transcripts were transcribed in vitro by T3 and T7 RNA
polymerases, respectively, using the Gemini Riboprobe system
(Promega Corp.). Riboprobes were subsequently precipitated
with ethanol/acetate, washed, and counted, and an average of 3.0
3 106 cpm/ml were generated for each probe. In situ hybridiza-
tion was performed as described previously (25). In brief, forma-
lin-fixed tissue sections were deparaffinized, digested with pro-
teinase K, and washed in 0.1 M triethanolamine buffer containing
0.25% acetic anhydride. Sections were incubated in 50 ml of hy-
bridization solution containing 35S-labeled riboprobe (2 3 104
cpm/ml) at 608C for 18 h in a humidified chamber and then
washed under stringent conditions and processed for autoradiog-
raphy for 15 d. Formalin-fixed preparations of IFN-g–treated
hTBECs were used as a positive control for RANTES mRNA
expression.
Statistical Analysis. Values for leukocyte adherence were ana-
lyzed for statistical significance using a one-way analysis of vari-
ance (ANOVA) for a factorial experimental design. The multi-
comparison significance level for the one factor analysis of
variance was 0.05. If significance was achieved by one-way analy-
sis, post-ANOVA comparison of means was performed using
Scheffe F tests.
Results
Polarity of T Cell Adhesion and Transmigration. Epithelial
cell monolayers (hTBECs) cultured on the underside of a
Transwell insert (to measure basal-to-apical transmigration)
exhibited consistent confluency (by microscopy) and con-
stant transepithelial resistance (by potential difference) that
was identical to that observed for standard upright culture
conditions (for measuring apical-to-basal transmigration).
Figure 1. Time dependence
of T cell adhesion (A) and trans-
migration (B) in the basal-to-api-
cal direction using epithelial cell
monolayers under the following
conditions: no stimulation of
monolayer or T cells (NS), T cell
stimulation with phorbol dibu-
tyrate (PDB; 50 ng/ml for 15
min), monolayer stimulation
with IFN-g (IFN; 100 units/ml
for 24 h), and stimulation of
both T cells and monolayers
(PDB/IFN). After these treat-
ments, 3 3 105 PBMCs were
added to each Transwell for 1
(white bars), 2 (gray bars), or 4
(black bars) h, and adherent and
transmigrated T cells were quan-
tified using anti-CD3 mAb and
immunofluorescence flow cy-
tometry as described in Materi-
als and Methods. Results are ex-
pressed as the percentage of T cells initially added to the monolayer
system. Each value is the mean 6 SEM (n 5 5 samples) and is representa-
tive of three experiments. A significant increase from unstimulated level is
indicated by *.1931 Taguchi et al.
Initial experiments with inverted (and upright) monolayers
each indicated that maximal T cell adhesion occurred within
1 h and remained at a stable level for 4–8 h, whereas T cell
transmigration exhibited a progressive and relatively linear
increase with time (Fig. 1). The time-dependent nature of
T cell transmigration was observed during unstimulated
control conditions and under conditions where adhesion
and transmigration were augmented by phorbol dibutyrate
treatment of T cells, IFN-g treatment of epithelial cells, or
a combination of the two treatments.
In comparing epithelial–T cell adhesion and transmigra-
tion in apical-to-basal versus basal-to-apical directions, we
observed that the efficiency of transmigration (i.e., the rela-
tive number of transmigrated to adherent cells) was in-
creased in the basal-to-apical direction (Fig. 2). Since the
total number of adherent plus transmigrated T cells was
similar in both directions, this efficiency reflected increased
retention of T cells adherent to the apical compared with
the basal epithelial cell surface, but increased transmigration
of T cells adherent to the basal compared with the apical
cell surface. The same patterns for preferential apical adhe-
sion and basal-to-apical transmigration was observed for a/b
and g/d T cell subsets (Fig. 3). However, the level of adhe-
sion and transmigration was augmented in g/d compared
with a/b T cells. These findings are in accord with the re-
quirement of LFA-1 activation for epithelial–T cell adhe-
sion and the higher level of activatable LFA-1 on g/d com-
pared with a/b T cells (8).
Pattern of ICAM-1 Expression in Monolayers. To deter-
mine the mechanism(s) for preferential T cell retention at
the apical cell surface and transmigration via the basal cell
surface, we first examined the distribution of ICAM-1 over
the epithelial cell surface. To localize ICAM-1 expression
on the apical and basolateral cell surfaces with respect to the
tight junction, we used a marker of the basolateral cell sur-
face (Na,K-ATPase) and visualized the z-axis of the mono-
layer by scanning laser confocal microscopy (Fig. 4). This
technique (in contrast to monolayer embedding and me-
chanical transection) preserved epitopes on the basal cell
surface and allowed us to document IFN-g–dependent ex-
pression of ICAM-1 in a circumferential pattern with uni-
form distribution along both the apical and basolateral cell
surfaces. Concomitant evidence for the functional signifi-
cance of apical and basolateral expression of ICAM-1 came
from measurements of ICAM-1–dependent adhesion and
transmigration in the presence of blocking mAbs directed
against ICAM-1 and LFA-1. Thus, IFN-g/phorbol dibu-
tyrate–stimulated levels of T cell adhesion and transmigra-
tion on apical (8, 9) or basal (Fig. 5) cell surfaces are re-
turned completely to control levels by anti–ICAM-1 F(ab)
or anti–LFA-1 mAb.
Contribution of RANTES to T Cell Adhesion and Transmi-
gration. In view of the observations that ICAM-1–LFA-1
interaction was unlikely to account for preferential move-
ment of T cells in the basal-to-apical direction, we per-
formed concomitant studies of chemokine function in the
airway epithelial cell model. Initial experiments indicated
that IFN-g stimulation of airway epithelial cells caused se-
lective expression of RANTES (but not macrophage inflam-
matory protein [MIP]-1a, MIP-1b, monocyte chemoattrac-
tant protein [MCP]-1, MCP-3, or eotaxin) (21). Accordingly,
we assessed the role of RANTES in mediating epithelial–T
cell adhesion and transmigration. As in the case of ICAM-1
and LFA-1, we assessed the contribution of RANTES for
increases in epithelial–T cell adhesion and transmigration
by treatment with a specific blocking mAb under stimula-
tion conditions that caused maximal adhesion and transmi-
gration. For hTBEC monolayers (using IFN-g stimulation
of monolayers and phorbol dibutyrate stimulation of T cells
to achieve maximal adherence and transmigration), mean
stimulated T cell adhesion and transmigration were inhib-
ited 58 and 80%, respectively, by anti-RANTES mAb (Fig.
Figure 2. T cell adhesion and
transmigration in the apical-to-
basal (A) and basal-to-apical (B)
directions. Aliquots of 3 3 105
PBMCs were added to Trans-
wells containing epithelial
(hTBEC) cell monolayers under
the same activation conditions as
described in Fig. 1. After a 4-h
adherence/transmigration pe-
riod, the adherent and transmi-
grated T cells were quantified
using anti-CD3 mAb and flow
cytometry. Results are expressed
as the percentage of T cells
added to the monolayer for ad-
herent (white bars), transmigrated
(striped bars), and adherent plus
transmigrated cells (black bars).
Each value is the mean 6 SEM
(n 5 5 samples) and is represen-
tative of three experiments. A
significant difference between
apical-to-basal versus basal-to-api-
cal values is indicated by *.
Figure 3. Adhesion and trans-
migration for a/b (A) versus g/d
(B) T cell subsets. Aliquots of
3 3 105 PBMCs were added to
Transwells containing epithelial
cell monolayers under the same
activation conditions as described
in Fig. 1. After a 4-h adherence/
transmigration period, the adher-
ent and transmigrated T cells for
each TCR-bearing subset were
quantified using anti-CD3, anti–
TCR-a/b, and anti–TCR-g/d
mAbs and flow cytometry as de-
scribed in Materials and Meth-
ods. Results are expressed as the
percentage of that subset for ad-
hered (white bars) or transmigrated (striped bars), as well as adherent plus
transmigrated cells (black bars). The percentages of T cell subsets in the
initial preparation bearing TCR-a/b- or -g/d was 95 and 5%, respectively.
Each value is the mean 6 SEM (n 5 5 samples) and is representative of
three experiments. A significant difference between g/d versus a/b values
was present for all conditions.1932 RANTES, ICAM-1, and Transepithelial T Cell Traffic
5). The low level of transmigration remaining despite a
maximally effective concentration of anti-RANTES mAb
may indicate the contribution of other (as yet unidentified)
chemoattractants derived from epithelial cells and/or T
cells. Nonetheless, taken together, the results indicate that
IFN-g–stimulated airway epithelial–T cell transmigration is
entirely dependent on ICAM-1–LFA-1 interaction and,
among chemokines, most significantly influenced by RANTES
interaction with its corresponding chemokine receptor
(CCR1, 4, or 5) on the T cell (26).
Pattern of RANTES Secretion. We next assessed the possi-
ble mechanism for RANTES to mediate a preferential di-
rectional movement of T cells across the epithelial cell
monolayer in the basal-to-apical direction. Initial experi-
ments indicated weak immunostaining of epithelial cells
with five different anti-RANTES Ab preparations, suggest-
ing that the secreted form of RANTES was responsible for
its functional effect. In view of this possibility, we reasoned
that transmigration might be mediated by a soluble chemi-
cal gradient for RANTES. Support for this possibility was
obtained with measurements of RANTES in media col-
lected from the apical versus basal aspect of the monolayers.
Thus, apical levels of RANTES were z16-fold higher than
basal levels under standard (upright) conditions for mono-
layer culture (Fig. 6). This differential level of RANTES
persisted even after: (a) correcting for the smaller volume of
media on the apical side of the cell monolayer (a fourfold
difference), (b) adding unactivated or phorbol dibutyrate–
activated T cells to the system, or (c) culturing cells in the
upright or inverted manner with respect to the Transwell
membrane (Figs. 6 and 7). The pattern for polarized secre-
tion of RANTES combined with uniform expression of
ICAM-1 was distinct for epithelial cells because endothelial
(HUVEC) cell monolayers exhibited nonpolarized secre-
tion of RANTES (Fig. 7) along with uniform expression
of ICAM-1 (27). To achieve significant endothelial cell
production (or maximal epithelial cell production) of
RANTES, it was necessary to stimulate cells with TNF-a
(in addition to IFN-g; references 21, 23), but the apical
distribution of RANTES secretion for epithelial cells was
Figure 4. Distribution of ICAM-1 over the apical and basolateral epithelial cell surfaces detected by scanning laser confocal microscopy. Cell monolay-
ers were treated with IFN-g (100 units/ml for 24 h), fixed in methanol, pretreated with 2% gelatin, and then incubated with anti–ICAM-1 mAb 84H10
(1 mg/ml) followed by FITC-conjugated goat anti–mouse IgG1 and with anti-Na,K-ATPase Ab followed by Cy-3–conjugated donkey anti–mouse IgG.
Photomicrographs of four scans at indicated intervals depict the pattern of immunofluorescence extending from the apical to basal cell surface for ICAM-1
(A–D) and Na,K-ATPase (E–H). No fluorescence was detected for monolayers stained with nonimmune IgG or with only anti–mouse IgG (data not
shown). Bar: 20 mm. 
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constant whether cells were stimulated with IFN-
 
g
 
 alone or
with IFN-
 
g
 
 in combination with TNF-
 
a
 
 (Fig. 7). Simi-
larly, the distribution of RANTES across the cell could not
be accounted for by diffusion of RANTES, because con-
centration gradients were maintained under these experi-
mental conditions for epithelial and endothelial cell mono-
layers (Figs. 6 and 7).
 
Pattern of ICAM-1 Expression and RANTES Secretion in
Airway Epithelium.
 
As discussed below, the relatively uni-
form distribution of ICAM-1 over the airway epithelial cell
surface was distinct for polarized epithelial cells, which (at
least in the case of colonic and alveolar epithelial cells) ap-
pear to limit expression of ICAM-1 to the apical surface (4,
28–30). To verify whether the pattern of ICAM-1 expres-
sion was representative of airway epithelium, we also deter-
mined the pattern of ICAM-1 presentation in endobron-
chial biopsies of airway epithelial tissue. The strategy was
aimed at obtaining airway epithelial tissue from healthy
control subjects that was stimulated ex vivo with IFN-
 
g
 
(just as was done for epithelial cell monolayers) to express
ICAM-1 or from asthmatic subjects that exhibited in-
creased expression of endogenous ICAM-1 compared with
nonasthmatic subjects even under baseline conditions (31).
In both cases, confocal microscopy indicated that the pat-
tern of ICAM-1 expression along the airway epithelial cell
surface was identical to the one observed for epithelial cell
monolayers. Thus, ICAM-1–expressing epithelial tissue ei-
ther stimulated ex vivo to express ICAM-1 or obtained
from asthmatic subjects that endogenously express ICAM-1
both exhibit expression uniformly along apical and basolat-
eral surfaces (Fig. 8).
We next aimed to determine whether evidence of
RANTES expression in isolated epithelial cells could also
be extended to studies of epithelial tissue from endobron-
chial biopsies. Initial experiments with IFN-
 
g
 
–stimulated
epithelial cells (as noted above) indicated immunostaining
was relatively weak (despite marked increases in corre-
sponding mRNA levels by Northern blot analysis and in
situ hybridization), and detection of RANTES signal above
background in immune cells (using tonsillar tissue) required
antigen-retrieval (data not shown). Accordingly, we used a
combination of antigen-retrieval immunostaining and in
situ hybridization to detect RANTES in endobronchial
biopsy tissue, but even these approaches indicated only low
levels of RANTES expression in epithelial tissue from
healthy control or asthmatic subjects under stable baseline
conditions (data not shown and Fig. 9). As discussed below,
these findings are similar to ones reported by others (32–35).
Figure 5.Effect of mAb on T
cell adhesion and transmigra-
tion. The epithelial–T cell sys-
tem was unstimulated (NS) or
stimulated with phorbol dibu-
tyrate and IFN-g (PDB/IFN) as
described in the legend to Fig. 1.
In addition, the PDB/IFN-stim-
ulated system was treated with
anti–ICAM-1 mAb R6.5 (50
mg/ml), anti–LFA-1b mAb (30
mg/ml), anti-RANTES mAb
(10 mg/ml), or nonimmune IgG
(50 mg/ml). The mAbs were added to both Transwell chambers 30 min
before the addition of PBMCs, or in the case of anti–LFA-1b mAb, the
PBMCs were pretreated for 30 min and then added to the chamber. After
a 4-h adherence/transmigration period, the adherent and transmigrated T
cells were quantified using anti-CD3 mAb and flow cytometry. Results
are expressed as the percentage of T cells added to the monolayer for ad-
herent (white bars), transmigrated (striped bars), and adherent plus transmi-
grated cells (black bars). Each value is the mean 6 SEM (n 5 5 samples)
and is representative of four experiments. A significant decrease from the
stimulated level is indicated by *.
Figure 6.Concentration gra-
dients of RANTES established
by cultured epithelial cells in the
apical (black bars) versus the basal
(gray bars) side of the monolayer.
Epithelial cell (hTBEC) mono-
layers were cultured upright in
Transwell chambers and then
were treated without (NS) or
with IFN-g (IFN, 100 units/ml)
for 24 h at 378C. After treat-
ment, monolayers were incubated without or with PBMCs (untreated or
treated with phorbol dibutyrate) for 4 h at 378C (as was done for adher-
ence/transmigration assays), and media from the upper (apical) and lower
(basal) chambers was collected for RANTES immunoassay. Each value is
the mean 6 SEM (n 5 3 samples assayed in triplicate). A significant differ-
ence for apical versus basal level of RANTES is indicated by *.
Figure 7.Levels of RANTES secreted by monolayer cultures of up-
right epithelial cells (A and D), inverted epithelial cells (B and E), and up-
right endothelial cells (C and F). Epithelial (hTBEC) and endothelial
(HUVEC) monolayers were cultured in Transwell chambers and then
were treated without (NS) or with IFN-g plus TNF-a (IFN/TNF; 100/
100 units/ml) for 24 h at 378C. After treatment, media from the upper
chamber (150 ml) and lower chamber (600 ml) was collected for
RANTES immunoassay. Each value is presented as the concentration (up-
per row, A–C) and the amount (lower row, D–F) of RANTES in the cham-
ber. All values represent the mean 6 SEM (n 5 3 samples assayed in trip-
licate). A significant difference for apical versus basal level of RANTES is
indicated by *.
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However, using a newly-developed protocol for controlled
exacerbation of asthma during monitored glucocorticoid
withdrawal, we observed a marked increase in expression
of RANTES that was localized to airway epithelial cells (as
well as an expanded population of immune cells) in asth-
matic subjects (Fig. 9). As was the case for IFN-g–stimu-
lated epithelial cells, the asthma-associated increase in epi-
thelial RANTES expression was more prominent by in situ
hybridization (that detects cell-associated mRNA) than
by immunostaining (that detects cell-associated protein).
Taken together, these findings suggest that secretion of
RANTES by airway epithelial cells is efficiently designed
to achieve an appropriate extracellular site of action.
Discussion
T cell traffic across epithelia is a critical feature of im-
mune barrier function, but the signals for movement and
their possible relationship to other polarized cell functions
were uncertain. Our results establish a model for transepi-
thelial T cell movement based on uniform and circumfer-
ential distribution of ICAM-1 along the cell surface and
polarized secretion of RANTES through the apical cell
surface. For ICAM-1, distribution on both apical and baso-
lateral cell surfaces allows for efficient cell adhesion at the
basal cell surface (to aid in transmigration) and at the apical
cell surface (for retention along the airway). For RANTES,
the pattern of preferential apical secretion provides for a
Figure 8. Representative pattern of ICAM-1 expression in airway epithelium induced ex vivo by IFN-g treatment or in situ by asthma. For ex vivo
experiments (A and B), endobronchial biopsy tissue was obtained from a healthy control subject and treated without (A) or with (B) IFN-g (100 units/
ml for 24 h). For in situ experiments (C and D), endobronchial biopsy tissue was obtained from normal control (C) or stable asthma (D) subjects. In all
cases, tissues were frozen, sectioned, pretreated with 2% gelatin, and then incubated with anti–ICAM-1 mAb 84H10 (1 mg/ml). Primary Ab binding was de-
tected with FITC-conjugated donkey anti–mouse IgG and was viewed using a scanning laser confocal photomicrography system. No fluorescence was de-
tected for monolayers stained with nonimmune IgG or with only anti–mouse IgG (data not shown). Bar: 20 mm.
Figure 9. Representative pattern of RANTES expression in airway epithelium in asthma exacerbation provoked by glucocorticoid withdrawal. Endo-
bronchial biopsy tissue was obtained from an asthmatic subject during treatment with inhaled glucocorticoid (A, C, and E) and after glucocorticoid with-
drawal (B, D, and F), and then processed either for immunostaining (A and B) or in situ hybridization (C–F) for RANTES. For immunostaining, tissues
were fixed in 10% formalin, embedded, sectioned, blocked with hydrogen peroxide, subjected to antigen retrieval, and then incubated with anti-
RANTES Ab. Primary Ab binding was detected using a biotinylated secondary Ab and a streptavidin–peroxidase complex, and tissues were then coun-
terstained with hematoxylin. Control staining with nonimmune IgG gave no detectable signal above background (not shown). Arrowheads, immunoposi-
tive epithelial cells and subepithelial immune cells. For in situ hybridization, formalin-fixed tissue sections were hybridized with 35S-labeled RANTES
cRNA, subjected to autoradiography, and imaged by brightfield (C and D) and darkfield (E and F) microscopy. Hybridization with 35S-labeled
RANTES RNA (sense probe) gave no detectable signal above background (data not shown). Arrowheads indicate junction of epithelial cell layer with
the basement membrane. Bar: 30 mm.1935 Taguchi et al.1936 RANTES, ICAM-1, and Transepithelial T Cell Traffic
soluble chemical gradient for T cell movement from the
subepithelium (where levels are low) to the mucosal surface
and maintenance there (where levels are higher). These
patterns for localization of ICAM-1 expression and RANTES
secretion found in isolated epithelial cells account appropri-
ately for the levels of T cell adhesion and transmigration
found in epithelial cell monolayers and with the available
data for ICAM-1 and RANTES expression in airway epi-
thelial tissue. Thus, ICAM-1 appears to be uniformly dis-
tributed around the mucosal epithelial cell surface under
conditions for exogenous stimulation with IFN-g or en-
dogenous expression with asthma, and RANTES appears
to be abundantly expressed and efficiently secreted by the
same population of airway epithelial cells during asthmatic
inflammation.
In attempting to understand the cellular mechanism for
sorting membrane proteins (such as ICAM-1) or secretory
proteins (such as RANTES), there is presently little infor-
mation for airway epithelial cells. In other models of polar-
ized epithelium (e.g., MDCK cells from kidney or CaCo-2
cells from intestine), it appears that membrane and secre-
tory proteins are distributed to the polarized cell surface by
exocytic and endocytic routes to varying degrees in differ-
ent epithelial cell types, but in both routes, sorting to the
apical domain is signal mediated and delivery to the baso-
lateral domain represents the default pathway (36, 37).
Thus, the apical pathway from the trans-Golgi network (for
the exocytic route) or endosomal recycling (for the en-
docytic route) requires specific sorting signals, whereas the
basolateral pathway represents the equivalent of the default
pathway in nonpolarized cells. The definitive identification
of sorting signals for transmembrane proteins is still uncer-
tain, but most examples are targeted via extracytoplasmic
domains, and in that regard, glycosyl phosphatidylinositol
(GPI)-membrane anchoring may act as a targeting signal
(38, 39). It is uncertain to what extent ICAM-1 might
completely fit this paradigm, but analysis of the homolo-
gous neural cell adhesion molecule (NCAM) indicates that
GPI-anchored forms are distributed to the apical surface,
whereas transmembrane forms are targeted to the basolat-
eral surface (40). For RANTES (or other b-chemokines),
no polarized sorting has been previously documented, so
no targeting signals have been defined (41).
The patterns for ICAM-1 expression and RANTES se-
cretion in airway epithelial cells provide initial evidence
of specialization and consequent cellular heterogeneity for
directing immune cell traffic. For example, other types of epi-
thelial cells (notably colonocytes and pneumocytes) express
ICAM-1 only along the apical cell surface (28–30). Perhaps
in this setting, ICAM-1 functions mostly in cell movement
along that surface or acts in concert with other cell adhe-
sion receptors to aid in host defense (e.g., as opsonins). En-
dothelial cells also appear to exhibit heterogeneity in the
pattern of ICAM-1 expression. Pulmonary capillary and
venular endothelial cells conserve this pattern of apical (lu-
minal) expression under basal or endotoxin- and cytokine-
stimulated conditions (4, 30). However, cytokine– (IL-1–)
induced ICAM-1 exhibits uniform apical and basolateral
expression over the surface of umbilical vein endothelial
cells and so may contribute to bidirectional movement of
immune cells across endothelium (27).
As was the case for ICAM-1, we found that RANTES
was distributed to both sides of an (umbilical vein) endo-
thelial cell monolayer. Our findings are consistent with a
report that endothelial cells are unable to generate a signifi-
cant gradient for other b-chemokines (MCP-1; reference
42). Endothelial cells remain polar in cell culture and ex-
hibit polarized secretion of a number of biologically active
molecules for directing immune cell traffic (43), suggesting
that these cells lack the sorting signals that are present in
some types of polarized epithelial cells for directing RANTES
to the apical cell surface. Instead, endothelial cells appear to
maintain proteoglycans capable of anchoring glycosami-
noglycan-binding chemokines to either cell surface (44–46).
Presumably, chemokine sequestration at the site of produc-
tion maintains a high local concentration despite potential
dilution by blood flow (47). After we submitted this report,
a study of IL-8 and RANTES indicated that binding to the
cell surface and transcytosis resulted in presentation of IL-8
and RANTES on both luminal and abluminal cell surfaces
of venular endothelium (48). Binding to the endothelial
cell depended on an intact COOH terminus (the immobi-
lization domain), but the lack of polarity for this process
(defined by administration of exogenous chemokine) indi-
cates that it is distinct from what we have observed for en-
dogenous RANTES production in epithelial cells. Further-
more, this nonpolar process might be expected to aid in
haptotaxis, and perhaps this is useful for movement out of
the circulation (often the predominant direction for im-
mune cell flux) or in recirculation of immune cells. How-
ever, a polar process (such as the one we describe for
RANTES) is required for effective chemotaxis and the
consequent need to preferentially direct immune cell
movement across the epithelium in a basal-to-apical direc-
tion. In fact, epithelial cells appear programmed to effi-
ciently release b-chemokines either in culture or in vivo.
Thus, endothelial cells may use nonpolarized expression of
proteoglycans to permit chemokine-dependent haptotaxis
of immune cells, whereas epithelial cells use polarized se-
cretion of chemokine to generate a soluble chemokine-
dependent gradient that mediates chemotaxis of immune
cells across the epithelium. In all cases, it appears that a cell
type–specific mechanism for directing RANTES secretion
(and ICAM-1 expression) works in combination with spe-
cific determinants in the chemokine (or cell adhesion mol-
ecule) structure to achieve specialized direction of immune
cell traffic.
We are unaware of other reports of transepithelial T cell
traffic, but several groups have studied neutrophil traffic
across epithelia. This work indicates that neutrophil trans-
migration across cultured airway epithelial and peritoneal
mesothelial cells also occurs preferentially in the basal-to-
apical direction and under some conditions may be medi-
ated by IL-8 production (17, 49). In the case of mesothelial
cells, IL-8 appears to be secreted at a slightly higher (one-
fold) rate towards the apical cell surface, but these determi-1937 Taguchi et al.
nations are influenced by back diffusion for this chemo-
kine. Nonetheless, the findings suggest that directionality
of chemokine secretion may also be used for parenchymal
cells to direct neutrophils into inflammatory sites. In that
regard, there are several reports describing the preferential
migration of neutrophils across cultured enterocytes. Sur-
face attachment of bacteria (Salmonella typhimurium) to in-
testinal T84 epithelial cells causes basolateral secretion of
IL-8 (four- to fivefold), indicating that this a-chemokine is
more likely responsible for recruiting neutrophils to the
subepithelial space rather than directing the final movement
of neutrophils across the epithelium in this cell system (50).
Intestinal T84 cells also respond to bacterial infection and
cytokines (including IFN-g) with expression of ICAM-1 on
the apical cell surface, and this pattern of expression is pre-
served in vivo (28, 29). The investigators noted that apical
expression of ICAM-1 by intestinal epithelial cells was a
sign that ICAM-1 (like IL-8) was not involved in the trans-
migration of neutrophils (28, 29). This position was sup-
ported by the finding that ICAM-1 blockade did not influ-
ence basal-to-apical transmigration of neutrophils through
intestinal epithelial monolayers in response to IFN-g (29),
presumably because neutrophils (unlike T cells) depend on
the interaction of Mac-1 (instead of LFA-1) with an alterna-
tive Mac-1 ligand such as heparan sulfate glycans (instead of
ICAM-1) (51). In this context, our results indicate that
controls for transepithelial T cell movement are distinct
from those controlling neutrophils and instead depend on
coordinated interaction of epithelial ICAM-1 and RANTES
with their corresponding immune cell receptors. The pre-
cise basis for the difference in T cell versus neutrophil trans-
epithelial migration will require defining the nature of the
chemokine stimulus for neutrophil transmigration. Similar
uncertainty accompanies the nature of the soluble factor
that regulates ICAM-1–dependent movement of mono-
cytes across epithelium or endothelium (27).
Our experiments focus on the epithelial determinants
(ICAM-1 and RANTES) of T cell transmigration, but
present (and previous) results indicate that T cells also con-
tain regulated determinants for adhesion and transmigra-
tion. Thus, a hierarchy for b1- and b2-integrin expression
among T cell subsets is linked to TCR gene usage and em-
phasizes g/d T cell adhesion (8), and accordingly transmi-
gration (our results). In particular, the higher levels of acti-
vatable LFA-1 on g/d versus a/b T cells result in higher
rates of adhesion and consequent transmigration. The find-
ings also confirm the importance of ICAM-1–LFA-1 inter-
action in regulating T cell transmigration as well as adhe-
sion. Analogous to the variable level of integrin expression,
the level of RANTES responsiveness also varies among T
cell subsets (52, 53). Initial studies indicate a higher level of
responsiveness in memory relative to naive T cells, al-
though responsiveness appears preserved among unacti-
vated and activated as well as CD41 and CD81 T cells (53).
The lack of preferential responsiveness to RANTES may
be a reflection of its capacity to use multiple b-chemokine
receptors, but the expression levels of receptors in relation
to T cells subsets (or TCR gene usage) is still only partly
defined (26). After we submitted this work for publication,
a report appeared indicating that RANTES may cause pref-
erential chemotaxis of Th1 type (IFN-g–producing) T cells
in vitro (54). As discussed below, this data may be taken to-
gether with our findings for induction of RANTES ex-
pression during asthma exacerbation to explain the seem-
ingly paradoxical enrichment of Th1 type T cells (detectable
after pharmacologic stimulation) in this disease (55). The
data also fit well with possible autoamplification of Th1
type T cell immune responses during conditions associated
with IFN-g production (such as respiratory viral infection;
reference 56). In support of this possibility, we find that in-
creases in ICAM-1 and RANTES expression localized to
airway epithelial cells are consistently detected in a mouse
model of viral bronchitis and hyperreactivity (57).
The relationship of RANTES responsiveness to transmi-
gratory capacity may be further complicated by the capac-
ity of RANTES to activate T cells (including activation of
b1- and b2-integrins on the T cell surface) as well as cause
chemotaxis (58–60). In fact, RANTES capacity for LFA-1
activation most likely accounts for the increased level of
ICAM-1–dependent adhesion of unactivated T cells (Fig.
5). The relatively weak effect of RANTES on adhesion
(compared with transmigration) is consistent with the rela-
tively weak effect on integrin (including b2-integrin) acti-
vation in other systems (59, 61). Thus, in the case of the
epithelium, the RANTES signal may confer some level of
adherence (via basal secretion), but it is predominantly
chemotactic (as a result of a more potent effect and a higher
level of agonist at the apical surface). The requirement for a
dual signal from ICAM-1 and RANTES is underscored by
findings that blockade of either signal blocks T cell transmi-
gration, and delivering either signal alone (e.g., by treat-
ment with exogenous RANTES in the absence of IFN-
g–stimulated ICAM-1 expression) is insufficient to mediate
transepithelial T cell traffic (Taguchi, M. and M.J. Holtz-
man, unpublished observation).
Our findings in isolated cells and in tissue now provide
for a more complete picture of immune cell traffic during
airway immunity and inflammation. In the setting of respi-
ratory viral infection, the stimulatory effect of IFN-g may
complement direct effects of the virus on epithelial cells to
augment ICAM-1 and RANTES expression and conse-
quent immune cell traffic (57, 62). In the setting of asthma,
we and others have also observed higher than normal ex-
pression of ICAM-1 in the airway epithelium (31, 63–66),
although the present and distinct use of confocal laser mi-
croscopy and frozen tissue appears to provide a more pre-
cise image of ICAM-1 localization in epithelial tissue. Most
reports indicate that RANTES is also expressed in the air-
way epithelium of normal and asthmatic subjects with mild
disease, but only at low basal levels in each group (32–35).
Accordingly, we sought an experimental protocol for en-
dogenous exacerbation of asthma that might reflect natural
flares of the disease. In that context, we developed a proto-
col for controlled glucocorticoid withdrawal that in some
subjects results in asthma exacerbation characterized by in-
creases in airway obstruction and immune cell infiltrate and1938 RANTES, ICAM-1, and Transepithelial T Cell Traffic
that is associated with a marked increase in expression of
RANTES localized to airway epithelial cells as well as im-
mune cells. Thus, the epithelial system for cell adhesion
and chemoattractant molecules appears engineered for host
defense, but the same molecular systems appear abnormally
activated in asthma depending on the severity of disease
and treatment conditions.
The molecular basis for overexpression of epithelial
ICAM-1 or RANTES in asthma is uncertain, since IFN-g
levels derived from Th1 type T cells are expected to be low
in this condition compared with viral infection (67). Con-
comitant work has confirmed that there is little detectable
IFN-g production in asthmatic subjects under baseline or
glucocorticoid-withdrawal conditions (Sampath, D., M.
Castro, and M.J. Holtzman, unpublished observation).
Even when airway tissue levels of IFN-g appear to be low,
however, there may be overactivation of IFN-g signal
transduction as evidenced by higher than normal levels of
signal transducer and activator of transcription 1 (Stat1) ac-
tivation (31). Thus, airway epithelial cells may be pro-
grammed for constitutive ICAM-1 expression (mediated
by Stat1-dependent transcription; references 5–7) and in-
ducible RANTES production (mediated by transcriptional
and post-transcriptional events; references 68, 69) even in
the apparent absence of viral infection or IFN-g produc-
tion. In the case of RANTES, inducible expression may
reflect a coincidental and subliminal response to virus that
does not result in IFN-g production, or perhaps more
likely may suggest an inherited or acquired propensity for
overexpression of the RANTES gene in these subjects in
response to a wider variety of inhaled stimuli. Defining
these relationships of RANTES expression to exogenous
and endogenous stimulation will require additional work
on the molecular basis for RANTES expression as well as
correlative protocols in human subjects. In the context of the
present work, however, the pattern of epithelial ICAM-1
expression and RANTES production appears consistent in
vitro and in vivo in healthy and diseased tissue, suggesting
that this combination of cell adhesion and chemoattractant
activities may efficiently regulate traffic of mucosal immune
cells during normal host defense and abnormal inflamma-
tory disease in the airway.
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